Skip to Content
Merck
  • Scintigraphic evaluation of cardiac metabolism in multicentric Castleman's disease.

Scintigraphic evaluation of cardiac metabolism in multicentric Castleman's disease.

Internal medicine (Tokyo, Japan) (2004-07-31)
Shinro Matsuo, Yasuyuki Nakamura, Ichiro Nakae, Tetsuya Matsumoto, Masahiko Takada, Kiyoshi Murata, Minoru Horie
ABSTRACT

A 72-year-old woman had insidious onset of heart failure, and was diagnosed as multicentric Castleman's disease. She underwent myocardial imaging with technetium-99m tetrofosmin, 1-123 beta-methyl-iodophenyl pentadecanoic acid (BMIPP). Technetium-99m tetrofosmin studies showed almost normal uptake of the left ventricular myocardium indicating normal myocardial perfusion. 1-123 BMIPP showed reduced uptake in the apical segment of the myocardium, indicating regional fatty acid metabolic abnormalities.

MATERIALS
Product Number
Brand
Product Description

Supelco
Pentadecanoic acid, analytical standard
Sigma-Aldrich
Pentadecanoic acid, ~99% (capillary GC)
Sigma-Aldrich
Pentadecanoic acid, 99%